E Wespes

Summary

Country: Belgium

Publications

  1. ncbi Smooth muscle pathology and erectile dysfunction
    E Wespes
    Department of Urology, C H U de Charleroi, Charleroi, Belgium
    Int J Impot Res 14:S17-21. 2002
  2. ncbi The ageing penis
    E Wespes
    Department of Urology, CHU de Charleroi, Belgium
    World J Urol 20:36-9. 2002
  3. ncbi EAU Guidelines on erectile dysfunction: an update
    Eric Wespes
    Hôpital Civil de Charleroi, Hopital Erasme, Urology Department, Boulevard Paul Janson 92, 6000 Charleroi, Belgium
    Eur Urol 49:806-15. 2006
  4. ncbi Current approaches to erectile dysfunction and testosterone deficiency
    E Wespes
    Department of Urology, CHU Charleroi, Hopital Erasme, Brussels, Belgium
    Minerva Urol Nefrol 62:431-5. 2010
  5. ncbi The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study
    Eric Wespes
    Gregorio Maranon Hospital, Madrid, Spain
    BJU Int 99:121-6. 2007
  6. ncbi Sildenafil non-responders: haemodynamic and morphometric studies
    Eric Wespes
    Department of Urology and Pathology, C H U de Charleroi, Charleroi and Hôpital Erasme, 808 Route de Lennik, 1070 Brussels, Belgium
    Eur Urol 48:136-9; discussion 139. 2005
  7. ncbi The place of surgery for vascular impotence in the third millennium
    Eric Wespes
    Department of Urology, C H U de Charleroi, Belgium
    J Urol 170:1284-6. 2003
  8. ncbi Erectile dysfunction and cardiovascular diseases
    E Wespes
    Department of Urology, CHU de Charleroi, Hopital Erasme, Brussels, Belgium
    Arch Esp Urol 63:649-54. 2010
  9. ncbi [Enuresis: treatments recognized by EBM]
    E Wespes
    Service d Urologie, C H U de Charleroi et Hôpital Erasme
    Rev Med Brux 31:351-5. 2010
  10. ncbi Male andropause: myth, reality, and treatment
    E Wespes
    Department of Urology, C H U de Charleroi, Charleroi, Belgium
    Int J Impot Res 14:S93-8. 2002

Collaborators

Detail Information

Publications22

  1. ncbi Smooth muscle pathology and erectile dysfunction
    E Wespes
    Department of Urology, C H U de Charleroi, Charleroi, Belgium
    Int J Impot Res 14:S17-21. 2002
    ..Further studies are necessary to explain the real role of testosterone not only on the peripheral mechanism of erection but also on the central control...
  2. ncbi The ageing penis
    E Wespes
    Department of Urology, CHU de Charleroi, Belgium
    World J Urol 20:36-9. 2002
    ..In human, testosterone seems to affect the central system rather than the peripheral mechanism of an erection. The role of ischaemia and the decrease in testosterone in the mechanism of erectile dysfunction are reviewed...
  3. ncbi EAU Guidelines on erectile dysfunction: an update
    Eric Wespes
    Hôpital Civil de Charleroi, Hopital Erasme, Urology Department, Boulevard Paul Janson 92, 6000 Charleroi, Belgium
    Eur Urol 49:806-15. 2006
    ..A panel of experts in this field has developed guidelines for the clinical evaluation and treatment based on the review of available scientific information...
  4. ncbi Current approaches to erectile dysfunction and testosterone deficiency
    E Wespes
    Department of Urology, CHU Charleroi, Hopital Erasme, Brussels, Belgium
    Minerva Urol Nefrol 62:431-5. 2010
    ..Associated with PDE5-I, testosterone supplementation is a treatment for the hypogonadic patients non responders to therapy. The article reviews the different aspects of the testosterone role in the pathophysiology of erection...
  5. ncbi The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study
    Eric Wespes
    Gregorio Maranon Hospital, Madrid, Spain
    BJU Int 99:121-6. 2007
    ..To evaluate whether patterns of sexual activity and efficacy over time to two dosing regimens of tadalafil differ with ageing in men with erectile dysfunction (ED)...
  6. ncbi Sildenafil non-responders: haemodynamic and morphometric studies
    Eric Wespes
    Department of Urology and Pathology, C H U de Charleroi, Charleroi and Hôpital Erasme, 808 Route de Lennik, 1070 Brussels, Belgium
    Eur Urol 48:136-9; discussion 139. 2005
    ..To better select sildenafil responders and non-responders, we have conducted a haemodynamic and morphometric study in sildenafil non-responders...
  7. ncbi The place of surgery for vascular impotence in the third millennium
    Eric Wespes
    Department of Urology, C H U de Charleroi, Belgium
    J Urol 170:1284-6. 2003
    ..We compared the sexual satisfaction rate in patients with arterial and/or venous impotence treated with 4 surgical techniques with long-term followup...
  8. ncbi Erectile dysfunction and cardiovascular diseases
    E Wespes
    Department of Urology, CHU de Charleroi, Hopital Erasme, Brussels, Belgium
    Arch Esp Urol 63:649-54. 2010
    ....
  9. ncbi [Enuresis: treatments recognized by EBM]
    E Wespes
    Service d Urologie, C H U de Charleroi et Hôpital Erasme
    Rev Med Brux 31:351-5. 2010
    ..Available evidence suggests that children with monosymptomatic nocturnal enuresis could be treated by bladder advice, the enuresis alarm and/or desmopressin. Therapy resistant cases should be handled by specialist centers...
  10. ncbi Male andropause: myth, reality, and treatment
    E Wespes
    Department of Urology, C H U de Charleroi, Charleroi, Belgium
    Int J Impot Res 14:S93-8. 2002
    ..Clinical response is a better guide to dose requirements, regardless of serum testosterone levels. This important field must be actively investigated by the medical, behavioral, and social sciences...
  11. ncbi Intracavernous injection as an option for aging men with erectile dysfunction
    E Wespes
    Department of Urology, CHU de Charleroi, , 1 6000 Charleroi, Belgium
    Aging Male 5:177-80. 2002
    ..The efficacy and safety of oral therapy and intracavernous injection are reviewed...
  12. ncbi Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?
    Thierry Roumeguere
    Laboratory of Experimental Medicine, CHU Charleroi, ULB, Montigny le Tilleul, Belgium
    BJU Int 104:511-7. 2009
    ....
  13. ncbi Sexual intercourse attempt patterns with two dosing regimens of tadalafil in men with erectile dysfunction: results from the SURE study in 14 European countries
    Ignacio Moncada
    Urology Department, , C/Dr. Esquerdo 46, Madrid 28007, Spain
    J Sex Med 2:668-74. 2005
    ..e., up to 36 hours. The two treatment regimens, on-demand and 3 times/week, provide an additional option and unique flexibility in dosing for men with ED and their partners...
  14. ncbi Complete phalloplasty using the free radial forearm flap for correcting micropenis associated with vesical exstrophy
    S de Fontaine
    Plastic Surgery and Urology Departments, University Hospital Erasme, Brussels, Belgium
    J Urol 166:597-9. 2001
    ..An inflatable prosthesis may be inserted in the flap to provide erection. The results of this technique have remained stable in the long term. This method provides a new tool for phalloplasty in these difficult cases...
  15. ncbi Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk
    Th Roumeguere
    Department of Urology, Erasme Hospital, University Clinics of Brussels, 808 Route de Lennik, B 1070, Brussels, Belgium
    Eur Urol 44:355-9. 2003
    ..The role of serum lipid levels has been demonstrated in coronary heart disease (CHD), but the relationship with ED is poorly documented. We evaluated undiagnosed hyperlipidemia in ED patients and their coronary heart disease risk...
  16. ncbi Presence of LDL modified by myeloperoxidase in the penis in patients with vascular erectile dysfunction: a preliminary study
    Karim Zouaoui Boudjeltia
    Experimental Medicine Laboratory, ULB 222 Unit, ISPPC, CHU de Charleroi, Hôpital A Vésale, Montigny le Tilleul, Belgium
    Eur Urol 51:262-8; discussion 268-9. 2007
    ..We have developed a new monoclonal antibody against LDL modified by MPO (Mox-LDL) and have used it on penile biopsies from patients operated on for penile implant...
  17. ncbi Guidelines on erectile dysfunction
    Eric Wespes
    , Urology Department, Belgium
    Eur Urol 41:1-5. 2002
    ..A panel of experts in this field have developed guidelines for clinical evaluation and treatment based on the review of available scientific information...
  18. ncbi Intriguing location of myeloperoxidase in the prostate: a preliminary immunohistochemical study
    Th Roumeguere
    Laboratory of Experimental Medicine, Unit 222, ULB, CHU Charleroi, Belgium
    Prostate 72:507-13. 2012
    ..Chronic or recurrent prostatic inflammation has long been recognized as having the potential to initiate and promote the development of prostate cancer. The objective was to investigate whether MPO is present in the prostate...
  19. ncbi [Erectile dysfunction and cardiovascular disease in clinical practice]
    T Roumeguere
    Service d Urologie, Hopital Erasme, Bruxelles
    Rev Med Brux 28:360-6. 2007
    ..ED can be treated safely and effectively in most men who have concomitant CVD...
  20. ncbi Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha
    Thierry Roumeguere
    Laboratory of Experimental Medicine, Unit 222, CHU Charleroi, Free University of Brussels, Montigny le Tilleul, Belgium
    Eur Urol 57:522-8. 2010
    ..In vitro, Mox-LDL triggered the inflammatory response by increasing the release of both interleukin 8 (IL-8) and tumor necrosis factor alpha (TNF-alpha) by endothelial cells (ECs) and monocytes respectively...
  21. ncbi Radical prostatectomy: a prospective comparison of oncological and functional results between open and laparoscopic approaches
    Thierry Roumeguere
    Department of Urology, Erasme Hospital University Clinics of Brussels, 808 Route de Lennik, 1070 Brussels, Belgium
    World J Urol 20:360-6. 2003
    ..We conclude that this prospective, comparative study shows that LRP, when performed in specialized centers, gives oncological and functional results comparable to open surgery...
  22. ncbi An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries
    Vincenzo Mirone
    University of Naples Federico II, A O U Federico II, Via S Pansini 5, Ed 5 80131, Napoli, Italy
    Eur Urol 47:846-54; discussion 854. 2005
    ..To examine the preference for 2 dosing regimens (on demand or 3 times/week) for tadalafil, a phosphodiesterase 5 inhibitor with a duration of effectiveness up to 36 hours in men with erectile dysfunction (ED)...